GSK plc. Registered in England and Wales No. 3888792.Registered office: 79 New Oxford Street, London. United Kingdom. WC1A 1DG> Modern Slavery Act statement 2023 (PDF - 139.1KB) GSK websites Locations selector Social media directory GSKPro for healthcare professionals GSK study ...
© 2001-2024 GSK plc. All rights reserved. Trade marks are owned by or licensed to the GSK group of companies. GSK plc. Registered in England and Wales No. 3888792. Registered office: 79 New Oxford Street, London. United Kingdom. WC1A 1DG > Modern Slavery Act statement 2023 (PDF -...
© 2001-2024 GSK plc. All rights reserved. Trade marks are owned by or licensed to the GSK group of companies.GSK plc. Registered in England and Wales No. 3888792.Registered office: 79 New Oxford Street, London. United Kingdom. WC1A 1DG...
Annual Report Global behind the science magazine GSK Global homepage Global investors Global mediaContinue to Company GSK This is our US website, intended for US audiences only. Other market sites can be reached by visiting our location selector. © 2001-2024 GSK plc. All rights reserved. ...
GSK plc (LSE/NYSE: GSK) announced today that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation for GSK5764227 (GSK’227), its B7-H3-targeted antibody-drug conjugate (ADC) being evaluated ...
517.44M * EPS estimates are Normalized unless otherwise noted. People Also Follow SymbolLast PriceChange AZN 65.68 -0.88% AstraZeneca PLC SNY 48.31 -0.86% Sanofi NVS 97.56 -0.84% Novartis AG MRK 98.78 -0.92% Merck & Co., Inc. BMY 56.75 -1.61% Bristol-Myers Squibb Company CompareSe...
© 2001-2024 GSK plc. All rights reserved. Trade marks are owned by or licensed to the GSK group of companies.GSK plc. Registered in England and Wales No. 3888792.Registered office: 980 Great West Road, Brentford, Middlesex, TW8 9GS, United Kingdom....
PHILADELPHIA--(BUSINESS WIRE)--GSK plc (LSE/NYSE: GSK) today announced positive topline data from the phase 3 trial in adults 50 years and older evaluating the immunogenicity, reactogenicity and safety of AREXVY (Respiratory Syncytial Virus Vaccine, Adjuvanted) when co-...
GlaxoSmithKline Pharmaceuticals Limited | Annual Report 2021-22 GSK plc at a glance Our purpose We unite science, technology and talent to get ahead of disease together For health impact + shareholder returns + thriving people About our new logo The new logo reflects our new purpose and growth ...
GSK plc (LSE/NYSE: GSK) and IDRx, Inc. (IDRx) today announced that they have entered into an agreement under which GSK will acquire IDRx, a Boston-based, clinical-stage biopharmaceutical company dedicated to developing precision therapeutics for the treatment of GIST. Under the agreement, GSK...